Bansal Drugs Private Limited
About Bansal Drugs Private Limited
Data last updated:
Bansal Drugs Private Limited is a private limited company based in Meerut, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 March 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24231UP1995PTC017799. Its GSTIN is 09AAACB5773A1ZX (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Neeru Agarwal and Nishant Raman.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Prachi Complexkhair Nagar Meerut, Uttar Pradesh, India – 250002.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.41 Cr, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹66,090 (net margin 0%) and EBITDA of ₹12.3 Lakh (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 20% over five years.
As per MCA filings, the company has open charges of ₹3.18 Cr and satisfied charges of ₹1.17 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Bansal Drugs Private Limited's registered office is in Meerut, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressPrachi Complexkhair Nagar Meerut, Uttar Pradesh, India – 250002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Bansal Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bansal Drugs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bansal Drugs Private Limited, buy the company report.
Financials of Bansal Drugs Private Limited
FY 2025 filings availableBansal Drugs Private Limited reported revenue of ₹13.41 Cr (up 37% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 37% growth in the latest year. EBITDA fell 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.3 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹66,090 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bansal Drugs Private Limited, buy the company report.
Board of directors of Bansal Drugs Private Limited
Bansal Drugs has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neeru Agarwal Also directs: Lra Learning Systems LLP | Director | 25 Oct 2022 | 4 Years 0 Months | Current |
| Nishant Raman Also directs: Lra Learning Systems LLP | Director | 16 Mar 2015 | 11 Years 7 Months | Current |
Peer comparison
Bansal Drugs Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sri Devi Distributors Private Limited | ₹13.52 Cr (FY 2024) | 30.0% | Chennai, Tamil Nadu, India | |||
| Ryvis Pharma Private Limited | ₹13.51 Cr (FY 2024) | 44.0% | New Delhi, Delhi, India | |||
| Vivan Acidchem Private Limited | ₹13.5 Cr (FY 2022) | 6.0% | Indore, Madhya Pradesh, India | |||
| Avrohn Pharma (I) Limited | ₹13.49 Cr (FY 2025) | 69.0% | Delhi, India | |||
| Bansal Drugs Private Limitedthis company | ₹13.41 Cr (FY 2024) | ₹66,090 | 0% | 37.0% | Meerut, Uttar Pradesh, India | |
| Kaveri Medi House Private Limited | ₹13.33 Cr (FY 2024) | -3.0% | Davanagere, Karnataka, India | |||
| San Medica Private Limited | ₹13.32 Cr (FY 2025) | 41.0% | New Delhi, Delhi, India | |||
| Feron Healthcare Private Limited | ₹13.31 Cr (FY 2025) | 28.0% | Secunderabad, Telangana, India |
To see the full peer comparison of Bansal Drugs Private Limited, buy the company report.
Auditor
Bansal Drugs Private Limited is audited by DEEPAK JAIN & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DEEPAK JAIN & CO. | FY 2023 | 001844C |
Shareholding
The shareholding of Bansal Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bansal Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Feb 2015 | 10569070 | Others | ₹3.18 Cr | Open | |
| 28 Mar 2011 | 10280907 | Indian Overseas Bank | ₹50 Lakh | Satisfied | |
| 18 Dec 2001 | 90275500 | Union Bank of India | ₹50 Lakh | Satisfied | |
| 01 Mar 1996 | 90274606 | Union Bank of India | ₹17 Lakh | Satisfied |
To see the full charge records of Bansal Drugs Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Bansal Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bansal Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bansal Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAACB5773A1ZX | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bansal Drugs Private Limited, buy the company report.
Recent activity
Bansal Drugs Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Rajendra Kumar ceased to be Director on 27 Oct 2022.
4 earlier events are in the company report.
Frequently asked questions
Bansal Drugs is an active private limited company based in Meerut, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 March 1995 (31+ years old) and is registered under CIN U24231UP1995PTC017799.
Bansal Drugs has 2 current directors:
- Neeru Agarwal - Director
- Nishant Raman - Director
The latest financial statements of Bansal Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bansal Drugs is 09AAACB5773A1ZX, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Bansal Drugs is U24231UP1995PTC017799. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bansal Drugs was incorporated on 31 March 1995, making it 31+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Bansal Drugs by revenue are Sri Devi Distributors Private Limited, Ryvis Pharma Private Limited, Vivan Acidchem Private Limited, Avrohn Pharma (I) Limited, Kaveri Medi House Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Rajendra Kumar ceased to be Director on 27 Oct 2022. Neeru Agarwal was appointed as Director on 25 Oct 2022. Gopal Dass ceased to be Director on 16 Mar 2015. Bansal Drugs has 4 board changes on record in total.
The registered office of Bansal Drugs is at Prachi Complexkhair Nagar Meerut, Uttar Pradesh, India – 250002.
Bansal Drugs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Bansal Drugs has open charges of ₹3.18 Cr and satisfied charges of ₹1.17 Cr as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
